VR Adviser’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,225,180
| Closed | -$5.58M | – | 41 |
|
|
2024
Q4 | $5.58M | Sell |
3,225,180
-5,774,820
| -64% | -$9.99M | 0.38% | 29 |
|
|
2024
Q3 | $18.1M | Hold |
9,000,000
| – | – | 0.95% | 26 |
|
|
2024
Q2 | $20.2M | Hold |
9,000,000
| – | – | 1.28% | 24 |
|
|
2024
Q1 | $25.8M | Sell |
9,000,000
-1,412,872
| -14% | -$4.05M | 1.23% | 23 |
|
|
2023
Q4 | $18.4M | Sell |
10,412,872
-4,031,572
| -28% | -$7.14M | 1.26% | 24 |
|
|
2023
Q3 | $45.6M | Buy |
+14,444,444
| New | +$45.6M | 4.81% | 5 |
|
|
2021
Q2 | – | Sell |
-120,649
| Closed | -$2.45M | – | 34 |
|
|
2021
Q1 | $2.45M | Buy |
120,649
+12,667
| +12% | +$257K | 0.27% | 27 |
|
|
2020
Q4 | $2.87M | Hold |
107,982
| – | – | 0.42% | 24 |
|
|
2020
Q3 | $2.6M | Buy |
+107,982
| New | +$2.6M | 0.51% | 20 |
|